4月 2026
- 首頁
- PYC Therapeutics
4月 2026PYC Therapeutics的市場佔有率分析
For more information or to learn how you can be involved with PYC, reach out and get in touch with one of our team members.
PYC Therapeutics(包含公司地區)
查看更多網站流量與參與度資訊- pyctx.com
PYC Therapeutics的熱門網域總造訪量
了解PYC Therapeutics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
PYC Therapeutics的熱門網域平均造訪時長
分析PYC Therapeutics參與度指標。
過去 3 個月平均造訪時長
子公司細目
PYC Therapeutics的熱門網域平均頁面瀏覽量
了解PYC Therapeutics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自PYC Therapeutics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞PYC Therapeutics Limited is developing drug candidate PYC-001.PYC Therapeutics (ASX:PYC) has announced progress in the clinical development of its investigational drug candidate PYC-001.
4月 15, 2026閱讀更多
新聞PYC Therapeutics Limited is developing PYC-001 on Apr 15th '26.PYC Therapeutics Limited (ASX:PYC) today announced a significant advancement in its clinical development program for PYC-001, an investigational drug candidate targeting Autosomal Dominant Optic Atrophy (ADOA).
4月 15, 2026閱讀更多
新聞PYC Therapeutics Limited hired Peter Coleman as Independent Non-Executive Chair on Nov 18th '25.PYC Therapeutics (ASX:PYC) has announced a significant step in its board renewal process, appointing former Woodside chief executive Peter Coleman as its new Independent Non-Executive Chair, effective immediately after the company's Annual General Meeting on 18 November 2025...
11月 13, 2025閱讀更多
查看所有PYC Therapeutics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
